The global patient engagement solutions market is on a trajectory of significant expansion, with projections indicating a robust CAGR of 10.2% during the forecast period from 2022 to 2028. Key drivers ...
DelveInsight's "CARVYKTI Market Size, Forecast, and Market Insight Report" highlights the details around CARVYKTI, a ...
On March 13, 2025, the UK Government announced that it was disbanding NHS England, the arm's length government body ...
As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promising clinical efficacy, durable responses, and growing ...
MoneyWeek on MSN3d
Labour's 'Project Chainsaw' begins by abolishing NHS England – will it backfire?Keir Starmer is taking the fight to the blockers, the NIMBYs, public sector workers and the unions, says Emily Hohler. What ...
[Get access to 10+ additional InvestingPro Tips for RENX and comprehensive analysis through the Pro Research Report, available exclusively to subscribers.] Renalytix AI’s EPS miss indicates ...
The FDA has approved Merck's (NYSE:MRK) STEGLATRO (ertugliflozin) for glycemic control in adults with type 2 diabetes (T2D). The... The FDA approves Merck's (MRK -0.2%) Steglujan (ertugliflozin ...
For many, the headline statistics on prescription spend is where the analysis ends. For example, The Health Foundations’ March 2017 chart of the month plotted the cost of drugs for the NHS in ...
InvestingPro analysis indicates the stock is trading near its Fair Value, with 8 additional exclusive insights available to subscribers. iCAD reported a smaller-than-expected loss, beating EPS ...
Both the NHS and pharma recognise the need and the opportunity to collaborate in order to improve patient care and outcomes, and this was a key theme for discussions at the recent HSJ Life ...
[Get access to 10+ additional InvestingPro Tips for RENX and comprehensive analysis through the Pro Research Report, available exclusively to subscribers.] Renalytix AI’s EPS miss indicates challenges ...
Back in 1934, Ralph Nelson Elliott discovered that price action displayed on charts, instead of behaving in a somewhat chaotic manner, had actually an intrinsic narrative attached. Elliot saw the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback